Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders.
about
Biomarkers in autismMitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysisButyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of ChildhoodImpairment of translation in neurons as a putative causative factor for autismEnteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disordersModulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.Studying autism in rodent models: reconciling endophenotypes with comorbiditiesUnique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.Glutamate excitotoxicity induced by orally administered propionic acid, a short chain fatty acid can be ameliorated by bee pollenIncrease of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders.Cerebral folate receptor autoantibodies in autism spectrum disorder.Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autismMass spectrometry as a tool for studying autism spectrum disorder.Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia.Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner.Selected biomarkers as predictive tools in testing efficacy of melatonin and coenzyme Q on propionic acid - induced neurotoxicity in rodent model of autism.Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.Reevaluating the hype: four bacterial metabolites under scrutiny.Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.Increased expression of fatty acid synthase and acetyl-CoA carboxylase in the prefrontal cortex and cerebellum in the valproic acid model of autismThe neurobiology of lipid metabolism in autism spectrum disorders.Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs.Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study.Autism: metabolism, mitochondria, and the microbiome.Autism spectrum disorder in a child with propionic acidemia.Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism.From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model.L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis.Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum DisorderGUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015
P2860
Q21129103-1A215B65-3799-4680-8A65-14C98E19148FQ24630557-B64BE3C3-9456-4E29-AAC5-85569F735FA5Q26766586-9A2767E8-F4CF-4412-BED4-858F34D6FC83Q28075770-C350D801-68F8-48F9-89DF-84BA57FBE763Q28540753-A6085B85-8E38-4134-A0C5-D949215C4A18Q28542649-9B88C7E9-8DFD-4628-9027-C1CB70E157C2Q30363954-D1B5F03E-25F8-4C00-A95C-956CE7938A80Q30404383-B3D2C753-3173-40B1-A755-A87AF95A3880Q30410996-A9AE472A-B883-4A80-9513-C8A54AF37FC4Q30451745-AB14A085-F3BC-496D-AFB8-83749C5D8157Q30534798-87C48498-8177-4D69-BEA8-033E40B4517BQ33716592-9AAE9351-3D3C-4BA2-B42D-15FCF53EF152Q33916678-000B2FD6-FD29-4A45-9011-57DBB7F86942Q34032586-761B2243-CCC9-4358-A37D-62642E007DF0Q34245893-1054436A-7973-48D4-AD2A-A4B11905E249Q34252062-7AB31A84-5B97-4CBF-BADE-AF5D3F234381Q34470350-A38A3CEB-482F-418D-8DFE-D8EE31BFE046Q35023635-E80E7F05-B2C3-4BC9-8029-665291550B50Q35086246-53C829BF-4504-49B3-A2AB-EB8AD9E4C094Q35102866-C39FD2EB-F35D-45D1-9744-96364B574BB0Q35232104-27B36201-8121-427C-9973-9ECEBDA6C809Q35426826-8B437BF2-DC76-45FB-95BD-430419BA9096Q37106022-1DBE00AA-3366-4C8F-B4CA-F44D8C2FFF2AQ37204659-0FCF1C91-47E2-4414-93A5-9500BA5F71B8Q37846445-C1BFC5B2-5891-425E-83BB-2A28738FA418Q38793435-660B7BC2-3756-407C-8673-4BA808799265Q42701655-EBD7DA79-75CC-48CE-8DB7-BDF4EB3E8CC3Q42790242-A326310F-3E1B-43E3-95C9-271C7C69CF2FQ43142854-98C913D3-C520-4E14-B555-2B5AE27E851BQ47640046-EC96F9FB-655B-4315-B339-05B33CC45249Q48159157-7500D83F-064C-4F0A-98FE-B796B6A0D4A4Q49979765-0D07BF84-C0CA-4741-B730-4EB04A7AFF4BQ50583315-27D97539-171D-45AC-9A0B-04CBE87605AFQ54958844-F8EC3137-69C4-4062-81A6-E6063C7EF716Q57922552-F752CF0B-0403-4362-A7A0-F174A99E16FBQ57954149-9872A34D-E1DB-4B12-8AB9-C7CB54438852
P2860
Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Altered brain phospholipid and ...... of autism spectrum disorders.
@en
Altered brain phospholipid and ...... of autism spectrum disorders.
@nl
type
label
Altered brain phospholipid and ...... of autism spectrum disorders.
@en
Altered brain phospholipid and ...... of autism spectrum disorders.
@nl
prefLabel
Altered brain phospholipid and ...... of autism spectrum disorders.
@en
Altered brain phospholipid and ...... of autism spectrum disorders.
@nl
P2093
P2860
P1476
Altered brain phospholipid and ...... of autism spectrum disorders.
@en
P2093
Derrick F MacFabe
Fred Possmayer
Jennifer R Mepham
Kelly A Foley
Lisa J Tichenoff
Raymond H Thomas
P2860
P304
P356
10.1111/J.1471-4159.2010.06614.X
P407
P577
2010-04-01T00:00:00Z